Loading...
Trading.HK
Global Markets
T.HK
News Markets

Menu

Home
Asia
Hong Kong China Japan India Singapore Taiwan
Americas
US Canada Brazil Mexico
Europe & Others
UK Germany France Australia
View All Markets →
Traditional Assets
Equities Options ETFs Bonds
Alternative Assets
Cryptocurrency Forex Commodities Macro Indicators
News
Market Analysis
Correlation Matrix Risk-Return Profile Market Sentiment Momentum Signals
View All Analytics →
Screener Compare Search Market Status
/ News / Markets

News

All News
By Category
Central Banks Commodities Corporate Corporate Actions Crypto Cryptocurrency Dividends Earnings Economic Data Forex IPOs Insider Trading Legal M&A Macro Market Update Markets Ratings Regulations Technology
Coverage
Methodology
FAQ

Novo Nordisk and Eli Lilly Can Sell Their Weight-Loss Drugs to Medicare Market

Published 3 days ago • Nov 6, 2025 at 6:34 PM • Negative
Novo Nordisk and Eli Lilly Can Sell Their Weight-Loss Drugs to Medicare Market

Related Stocks

AZN.ST AstraZeneca PLC AZNN.MX AstraZeneca PLC NOVO-B.CO Novo Nordisk A/...
The agreement, announced by the White House, potentially unlocks a major new market for the mega-blockbuster drugs.

Continue Reading

View Comments

More News

This Congresswoman’s Bet on Amazon.com (AMZN) Was Profitable

54 minutes ago Negative

Aktietilbagekøbsprogram - uge 45

58 minutes ago Negative

Share buyback programme - week 45

58 minutes ago Negative

BOJ summary indicates chances of December interest rate hike

1 hour ago Positive

Subaru Corp H1 Earnings Drop; Reaffirms FY Outlook

1 hour ago Negative

Trading.HK

Your comprehensive platform for global financial markets data, analytics, and insights.

Markets

  • Asia Pacific
  • Americas
  • Europe
  • Market Status

Asset Classes

  • Equities
  • Cryptocurrency
  • ETFs
  • Forex
  • Commodities

Resources

  • Market News
  • Analytics
  • Stock Screener
  • Compare Stocks
  • Methodology
  • Coverage
  • FAQ

© 2025 Trading.HK. All rights reserved.

Privacy Policy Terms of Service Contact